Exro Announces C$30 Million Bought Deal Financing
- Exro Technologies has entered into an agreement with Canadian underwriters for a bought deal financing of 13,500,000 common shares at a price of C$2.25 per share, resulting in gross proceeds of C$30,375,000. The underwriters also have an option to purchase an additional 2,025,000 common shares for additional gross proceeds of up to C$4,556,250. The net proceeds will be used for capital expenditure, working capital obligations, and general working capital purposes.
- None.
The Company has granted the Underwriters an option to purchase up to an additional 2,025,000 Common Shares (the "Over-Allotment Option Common Shares" and together with the Common Shares, the "Offered Securities") to cover over-allotments, if any, and for market stabilization purposes at a price of
The Company intends to use the net proceeds from the Offering to meet the capital expenditure and working capital obligations associated with certain strategic partnership and collaboration agreements, and for general working capital purposes.
The Common Shares will be issued by way of a prospectus supplement that will be filed in all provinces of
The Offering is scheduled to close on or about May 23, 2023, and is subject to certain conditions including, but not limited to, the receipt of all necessary regulatory and other approvals including the approval of the Toronto Stock Exchange and the securities regulatory authorities.
The securities offered in the Offering have not been, and will not be, registered under the
Exro Technologies Inc. is a leading clean technology company that has developed new generation power control electronics that change how the world optimizes energy by expanding the capabilities of electric motors and batteries. The company's innovative technologies serve to bridge the performance-cost gap in e-mobility (Coil DriverTM) and stationary energy storage (Cell DriverTM), and act to accelerate adoption towards a circular electrified economy by delivering more with less – minimum energy for maximum results.
For more information visit our website at www.exro.com.
To view our Corporate Presentation visit us at www.exro.com/investors.
Visit us on social media @exrotech.
This news release contains forward-looking statements and forward-looking information (together, "forward-looking statements") within the meaning of applicable securities laws. All statements, other than statements of historical facts, are forward-looking statements. Generally, forward-looking statements can be identified by the use of terminology such as "plans", "expects", "estimates", "intends", "anticipates", "believes" or variations of such words, or statements that certain actions, events or results "may", "could", "would", "might", "will be taken", "occur" or "be achieved". Forward looking statements involve risks, uncertainties, and other factors disclosed under the heading "Risk Factors" in the Company's 2022 Annual Information Form (available at www.sedar.com) and elsewhere in filings with Canadian securities regulators, that could cause actual results, performance, prospects, and opportunities to differ materially from those expressed or implied by such forward-looking statements. In the event the Offering is not completed, the Company may need to source alternative forms of financing that may lead to delays in fulling its commitments under certain strategic partnership and collaboration agreements. Although the Company believes that the assumptions and factors used in preparing these forward-looking statements are reasonable based upon the information currently available to management as of the date hereof, actual results and developments may differ materially from those contemplated by these statements. Readers are therefore cautioned not to place undue reliance on these statements, which only apply as of the date of this news release, and no assurance can be given that such events will occur in the disclosed time frames or at all. Except where required by applicable law, the Company disclaims any intention or obligation to update or revise any forward-looking statement, whether as a result of new information, future events, or otherwise.
This information is qualified in its entirety by cautionary statements and risk factor disclosure contained in filings made by the Company with the Canadian securities regulators, including the Company's annual information form for the financial year ended December 31, 2022, and financial statements and related MD&A for the financial year ended December 31, 2022, filed with the securities regulatory authorities in certain provinces of
Neither the Toronto Stock Exchange nor the Investment Industry Regulatory Organization of
View original content to download multimedia:https://www.prnewswire.com/news-releases/exro-announces-c30-million-bought-deal-financing-301825206.html
SOURCE Exro Technologies Inc.
FAQ
What is the financing agreement between Exro Technologies and Canadian underwriters?
What is the price per share in the bought deal financing?
What is the total gross proceeds from the financing?